Osteoarthritis (OA) is a chronic degenerative joint disease, where chondrocyte apoptosis is responsible for cartilage degeneration. Bax is a well-known proapoptotic protein of the Bcl-2 family, involved in a large number of physiological and pathological processes. However, the regulation mechanisms of Bax underlying chondrocyte apoptosis in OA remain unknown. In the present study, we determined the role of Bax in human OA and chondrocyte apoptosis. The results showed that Bax was upregulated in chondrocytes from the articular cartilage of OA patients and in cultured chondrocyte-like ATDC5 cells treated by IL-1 . Bax was identified to be the direct target of miR-29a by luciferase reporter assay and by western blotting. Inhibition of miR-29a by the mimics protested and overexpression by miR-29a inhibitors aggravated ATDC5 apoptosis induced by IL-1 . These data reveal that miR-29a/Bax axis plays an important role in regulating chondrocyte apoptosis and suggest that targeting the proapoptotic protein Bax and increasing expression levels of miR-29a emerge as potential approach for protection against the development of OA.
Introduction
Osteoarthritis (OA) is a common degenerative disease of the human articular cartilage and subchondral bone, characterized by destruction of articular cartilage, formation of osteophytes, synovitis, and intra-articular inflammation [1, 2] . Its clinical symptoms include pain, stiffness, and loss of mobility. Variable factors have been indicated to be responsible for the risk of OA, such as aging, failure of nutrient supply, and joint injury, and chondrocyte loss has been implicated as one key event in the development of OA [3] . Compared to normal cartilage, patients with OA show chondrocyte carrying apoptotic features [4, 5] . It is known that interleukin-1beta (IL-1 ) plays pivotal roles in the pathogenesis of OA [6] . IL-1 activation induces apoptosis of chondrocytes in both normal and OA cartilage in a dose-dependent manner [5] . IL-1 treatment causes mitochondrial dysfunction and energy depletion in chondrocyte-like ATDC5 cell [7] . Moreover, IL-1 treatment increases the expression level of proapoptotic Bcl-2 family proteins [8, 9] . Here, IL-1 induced cell model was selected to reveal the mechanisms of chondrocyte apoptosis in the current study.
Bax, a proapoptotic protein of the Bcl-2 family, is critical for execution of apoptosis [10] . Upregulation and activation of Bax have been determined in many apoptotic models, such as androgen stimulated osteoblast and osteocyte apoptosis [11] , BMP-2 induced osteoblast apoptosis [12] , recombinant IL-1 induced cell cycle arrest, and apoptosis in neural precursor cells [13] and in cancer cell apoptosis [14, 15] . Genetic knockdown or knockout of Bax significantly suppresses cellular apoptosis, indicating the importance of the conserved mechanism of Bax-mediated cell apoptosis. However, the regulation mechanisms of Bax underlying chondrocyte apoptosis in OA remain to be explored.
MicroRNAs (miRNAs or miRs) are a family of ∼22-nucleotide small, single stranded noncoding RNAs that regulate multiple genes by mediating mRNA cleavage and destabilization, involved in a variety of physiological functions 2 BioMed Research International and disease processes, including OA [16, 17] . It is known that miRNAs play an important role in mediating the effect of many risk factors for OA, such as aging [18] , immune response [19, 20] , pain [21] , and inflammation [22, 23] .
Collective data indicate that miRNA may play a critical role in regulating chondrocyte apoptosis in OA cartilage. miR146a contribute to OA pathogenesis by inducing chondrocyte apoptosis via Smad4 [24] . Silencing of miR-34a reduces IL-1 induced chondrocyte apoptosis in vitro [25] . Besides, many other miRNAs were involved in the pathogenesis of OA, such as miR-448 [26] , miR-21 [27] , and miR-142-3p [28] . Moreover, the level of miR-29a in knee cartilaginous tissue of OA patients was significantly decreased, compared with normal cartilage samples [29] , indicating the importance of miR-29a in the development of OA.
The role and detailed regulation mechanisms of Bax in OA remain to be elucidated. Whether miRNA could regulate Bax expression that contributes to chondrocyte apoptosis is largely unknown. Therefore, this work aims to elucidate the role of Bax, regulated by miRNA, in regulating chondrocyte apoptosis and pathogenesis of OA. 
Material and Methods

Human Articular
Western Blotting.
Western blotting was applied as previous reported [31] . Briefly, cell lysates were collected, and protein concentration was determined by Bradford assay. Then 20 g of total protein from each sample was separated by SDS-polyacrylamide gel electrophoresis (PAGE). Then proteins were transferred onto PVDF membranes, blocked with 5% BSA for 1 hour, and incubated overnight at 4 ∘ C with primary antibodies against Tubulin, Bax, PUMA, total caspase-3, or cleaved (activated) caspase-3 (all purchased from Cell Signaling Technology, Danvers, MA, USA). After washing, membranes were incubated with secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA) for 60 min and bands were visualized using ECL chemiluminescence system (Beyontime, Zhenjiang, Jiangsu, China). Densitometric analysis was performed using ImageJ software (1.47v, US National Institutes of Health, USA). Band intensities were normalized to Tubulin in control group.
miRNA, 3'UTRs, and Luciferase Reporter
Assay. DNA fragments containing miR-29a hairpin were cloned into IRES-GFP vector (Promega, Madison, WI, USA) for overexpression. Wildtype (miR-29a-WT) and mutated (miR-29a-MUT) miR-29a were shown in Figure 3 (f). The sequence of Bax 3'UTR within miR-29a binding site was subcloned into pMiR-luciferase report vector (Promega). Dual-Luciferase5 Reporter Assay System (Promega, Madison, WI, USA) was employed to measure the luciferase activities after transfection, accordingly [32] . Wildtype (Bax-WT) and mutated (Bax-MUT) bax were shown in Figure 3 (f). miRNA transfection control, negative control, miR-29a mimic, and inhibitor were purchased from Genepharma (Shanghai, China).
Quantitative Real-Time PCR (qPCR).
Total RNA was isolated by TRIzol (Invitrogen). For miRNA extraction, reverse transcription was performed with TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA, USA), according to the instruction. Then PCR reactions were conducted with predesigned primers for miR-29. The following sense and antisense primers were used: miR-29a 5 -CTGATTTCTTTTGGTGTTCAG-3 5 -AACCGATTT-CAGATGGTGC-3 ; miR-29b 5 -CATATGGTGGTTTAG-ATTT-3 5 -AACACTGATTTCAAATGGT-3 ; miR-29c 5 -CGATTTCTCCTGGTGTTCA-3 5 -ACCGATTTCAAA-TGGTGC-3 ; -actin 5 -AAATCTGGCACCACACCTTC-3 5 -GGGGTGTTGAAGGTCTCAAA-3 .
Statistical
Analysis. Data represent as means ± SD from at least 3 independent experiments for n > 3 cultures. Statistical analyses were performed by Graphpad Prism 7.0 software (GraphPad Software Inc., La Jolla, USA). The P-values were calculated by using a two-way analysis of variance (ANOVA) followed by Bonferroni test (for more than two groups), or two-tailed student's t-test (within two groups). A value of p < 0.05 was considered significant.
Results
Bax Is Upregulated in the Cartilages of OA Patients and in Cultured
Chondrocytes from OA Patients. Although known as the toxic proapoptotic protein, the role of Bax in chondrocyte apoptosis is less known, especially the detailed mechanisms. Thus, we first determined the expression level in the cartilage isolated from OA patients, by immunohistochemical staining. When compared to the normal control, the expression of Bax was significantly upregulated in the chondrocyte of OA patients (Figure 1(a) ). The staining was quantified, and data showed that Bax level was found increased more than 2-fold in OA patients (Figure 1(b) ). Further, chondrocytes from clinical samples were isolated and cultured. By comparing to control chondrocytes, cells from OA patients showed remarkedly upregulated Bax protein level (Figure 1(c) ). PUMA, another proapoptotic protein as Bax, was reported to be involved in the regulation of OA [8] . Accordingly, the expression level of PUMA was also upregulated revealed by western blot analysis (Figure 1(c) ). On the other side, the levels of antiapoptotic protein Bcl-2 were also evaluated and showed no statistical differences (Figure 1(c) ). Furthermore, the levels of activated Caspase-3 were also upregulated in cells from OA samples (Figure 1(c) ), as reported showing apoptotic features [4, 5] . The statistical data were shown in Figure 1(d) . Taken together, these data showed that Bax protein level was significantly upregulated in the chondrocytes in OA patients.
Bax Is Upregulated in Chondrocyte-Like ATDC5 Cells under IL-1 Treatment.
To further explore the regulation of Bax in OA, we cultured ATDC5 as described in the material and method section. Then the chondrocyte-like ATDC5 cells were incubated with IL-1 to mimic the pathogenesis of human OA chondrocytes [5] . We first determined whether IL-1 exposure would induce ATDC5 apoptosis, by using nuclei staining. As shown in Figure 2(a) , treatment of IL-1 for 24 h significantly induced ATDC5 apoptosis with increased condensed or fragmented nuclei, in a dose dependent manner (Figure 2(b) ). Also, IL-1 exposure induces ATDC5 apoptosis in a time dependent manner (Figures 2(c)  and 2(d) ). Next, the expression levels of Bax were determined.
As shown in Figure 2 (e), treatment of IL-1 significantly induced the expression of Bax, in a time dependent manner. Meanwhile, as previously shown, PUMA was also increased after IL-1 treatment. The expression levels of Bcl-2 were downregulated upon IL-1 treatment and the expression levels of apoptotic activated Caspase-3 and Cytochrome c were markedly increased (Figures 2(e) and 2(f) ). These data indicate that IL-1 exposure induces chondrocyte-like ATDC5 cell apoptosis and Bax is significantly upregulated in ATDC5 cell under IL-1 treatment.
Bax Is the Direct Target of miR-29a.
Bax is important for IL-1 induced chondrocyte apoptosis; however, the regulation mechanisms of Bax in OA remain to be determined. Bioinformatical analysis tool (Targetscan) shows that Bax is a potential target of miR-29. The miR-29 binding site in the Bax 3'UTR is conserved among many vertebrates, such as human, mouse, rat, cat, and elephant (Figure 3(a) ). The miR-29 family in human consists of miR-29a, miR29b, and miR-29c, differing in only two or three bases. The genomic organization of human miR-29 was represented in Figure 3 (b). We determined the expression level of miR-29 in cultured cells from control or OA patients. The quantitative PCR result showed that, in OA patients, only the level of miR-29a was significantly decreased, while miR-29b and miR-29c remained unchanged (Figure 3(c) ). To determine whether Bax is the direct target of miR-29a, luciferase assay was performed. We constructed luciferase reporter containing wild type (Bax-WT) or mutated (Bax-MUT) 3'UTR of Bax and expression vectors of wild type (miR-29a-WT) or seed mutated (miR-29a-MUT) miR-29a (Figure 3(d) ). We cotransfected cells with luciferase reporter of Bax-WT or Bax-MUT with miR-29a. The result showed that miR-29a reduced luciferase activity of Bax-WT, whereas miR-29a failed to affect the luciferase activity of Bax-MUT (Figure 3(e) ). Cotransfection of wild type 3'UTR of Bax and miRNA (miR-29a-WT or miR-29a-MUT) expression vector showed that miR-29a-WT transfection significantly reduced the level of luciferase activity, but not miR-29a-MUT with seed mutation (Figure 3(f) ). Taken together, these data demonstrate that Bax is the direct target of miR-29a.
miR-29a/Bax Axis Contributes to IL-1 Induced
Chondrocyte-Like ATDC5 Apoptosis. Our preliminary experiments transfected cells with miR-29a plasmids (vector or seed mutant). Since transfection with plasmid was variable than nucleotide, thus, we synthesized miR-29a mimic and inhibitor. We determined the efficiency and nontoxic concentration for transfection in ATDC5 cells and found that 30 pmol mimic or inhibitor was appropriate for transfection without overt toxicity (Figures 4(a) and 4(b) ); and 30 pmol was used for subsequent experiment.
After demonstration of direct regulation of miR-29a to Bax, we tested the role of miR-29a/Bax in IL-1 induced chondrocyte-like ATDC5 apoptosis. Cultured ATDC5 cells were transfected with miR-29a mimic or inhibitor, or control. Then, cells were treated with or without (Non) 10 ng/ml IL-1 for 48 h to induce chondrocyte-like ATDC5 cell apoptosis. Bax protein level was significantly increased under IL-1 in control group and miR-29a mimic decreased and miR-29a inhibitor increased Bax protein levels markedly, comparing to the corresponding control (Figures 4(c) and 4(d)). Furthermore, the protein levels of PUMA and cleaved caspase-3 showed the same trend as Bax (Figure 4(c) ). To test if altering miR-29a levels affect IL-1 induced ATDC5 apoptosis, miR-29a mimics or inhibitors were transfected into ATDC5 cells. Apoptotic assay was performed, and the results revealed that miR-29a mimics decreased while miR29a increased significantly the apoptosis rate (Figures 4(e) and 4(f)). Collectively, these data indicate that miR-29a/Bax axis plays an important role in IL-1 induced chondrocytelike ATDC5 apoptosis.
Discussion
In this study, we demonstrated that expression level of Bax was increased in cartilage tissues of OA patients and in cultured human OA chondrocyte. Furthermore, administration of IL-1 significantly induced Bax and PUMA upregulation, activation of Caspase-3, and finally apoptosis of chondrocyte-like ATDC5 cells. Expression level of miR29a was markedly downregulated with in OA patients. Bax was identified as the direct effect target of miR-29a during IL-1 induced ATDC5 apoptosis. Modulation of miR-29a controlled the expression levels of Bax and PUMA, activation of Caspase-3, and cell apoptosis. The graphic schematic diagram shows the summary of our hypothesis (Figure 4(g) ).
Taken together, we specified the important role of miR29a/Bax axis in the regulation chondrocyte apoptosis in OA.
OA is the most common disease of articular cartilage, where loss and abnormal remodeling of the matrix occurred [33] . Chondrocyte is the only cell type in the articular cartilage and chondrocyte death has been considered as a possible mechanism of OA pathology [34] . Studies showed that apoptosis occurred more frequently in OA cartilage than in normal cartilage [5, 35] . And chondrocyte apoptotic rate was positively correlated to cartilage degradation/severity of OA. However, revealed by TUNEL assay, the apoptotic rate varies from 6% [36] and 19% [5, 37] to 88% [38] . Furthermore, a recent study showed that chondrocyte death reduces catabolic cartilage damage in murine posttraumatic OA [39] . Thus, the relationship between chondrocyte loss and cartilage degeneration needs to be further explored. Bax is one of the apoptotic executors belonging to the BH3-only subgroup of Bcl-2 family proteins [40, 41] . Upon apoptotic stimuli, Bax can be activated and oligomerized into the mitochondrial outer membrane and induce the release of Cytochrome c and activate caspase proteins [42] . Bax regulation has been implicated in many pathological processes such as neuronal degenerative disease and cancer [43] . However, the role of Bax in chondrocyte apoptosis in human OA remains largely unknown. Compared to OA lesional area in cartilage tissues from the same patient, the level of Bax remained unchanged in nonlesional area [35] . In 2015, Karaliotas GI and et al. reported that Bax mRNA level shows an increasing trend in OA patients without statistically significance; however, the level of Bax was markedly increased in stage III OA patients [44] . Thus, the role of Bax expression in OA is revealing. In the current study, we collected cartilage tissues from OA patients and analyzed the protein expression levels of Bax. By immunohistochemical and western blot, Bax expression level was found significantly upregulated in OA samples. Although we did not distinguish the OA stage of our patients, the age distribution was found close to that in the report, indicating the potential consistence [44] .
On the other side, the ratio of Bcl-2/Bax is critical in regulating cell apoptosis. Bcl-2 is an antiapoptotic Bcl-2 family protein, which is consistently downregulated in the apoptosis process [45] , leading to the decreased Bcl-2/Bax during cell apoptosis. The imbalance of Bcl-2/Bax also occurred in OA animal model and in cartilage tissues from OA patients [44, 46, 47] . We found that the levels of Bcl-2 proteins showed no changes between normal cartilage and OA samples ( Figure 1 ) and Bcl-2 expression was downregulated in IL-1 induced ATDC5 apoptosis (Figure 2) . Thus, the dysregulated Bcl-2/Bax ratio was found to contribute to chondrocyte apoptosis in the current study. Furthermore, Bax/Bcl-2 ratio imbalance has been reported to mediate miR-29a induced fibroblast apoptosis [48] and Bax has been determined as a direct target of miR-29b in myocardial apoptosis [49] . Moreover, miR29b targets a variety of BH3-only genes, including Bim, Bmf, Hrk, Puma, and N-Bak, to regulation neuronal maturation and apoptosis [50] . However, the regulation mechanism of Bax in OA development remains unclear. Bioinformatic analysis revealed the potential regulation of miR-29 toward Bax, and by luciferase reporter assay we confirmed that Bax was the direct target of miR-29a and the miR-29a/Bax axis contributed to the regulation of IL-1 induced ATDC5 apoptosis. Human miR-29 family consists of three members, miR29a, miR-29b, and miR-29c [51] . Due to the homogenous sequences, they share overlapping target. However, differed roles have been reported [52] . In regulation OA, all three miR-29s have been reported to increase in human hip OA samples, whereas downregulated miR-29s have been found in cultured human OA chondrocyte [53] . Additionally, miR-29c is increased in the plasma of patients with primary OA [54] . Moreover, miR-29a is downregulated in human hip and knee OA articular cartilage and shows a negative correlation of miR-29a with body mass index (BMI) while IL-1 positively correlates with BMI [29] , indicating the inhibition effect of IL-1 on miR-29a expression in OA. Further, miR-29a is downregulated and miR-29a deficiency exacerbates synovitis pathogenesis and fibrosis in the end-stage of OA knees [55] . In the current study, miR-29a was downregulated in OA cartilage samples, resulting in the upregulation of miR-29a targeted Bax and ultimately chondrocyte apoptosis. Thus, the role of miR-29 in OA is revealing and the results differ because of individual differences of collected samples. Large scale of OA cartilage tissues may be needed to further identify the role of miR-29a in the development of OA.
In summary, the present study determines that miR29a/Bax axis plays an important role in chondrocyte apoptosis in OA. Upon OA stimuli, the levels of miR-29a are downregulated and Bax expression is increased, leading to the activation of Caspase-3 protein and finally chondrocyte apoptosis. These findings provide new evidence for the understanding of OA development and new strategies for OA caring in the future.
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